Literature DB >> 6348988

Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.

R K Sibley, J Rynasiewicz, R M Ferguson, D Fryd, D E Sutherland, R L Simmons, J S Najarian.   

Abstract

Cyclosporine nephrotoxicity is a common and usually reversible cause of renal insufficiency in the renal allograft recipient. We examined 132 renal biopsy specimens of 54 patients with elevated serum creatinine concentrations in the posttransplant period in an attempt to characterize histologic features that would identify patients with cyclosporine nephrotoxicity as opposed to those with acute rejection. Nine histologic parameters were examined--vasculitis, interstitial edema, distribution and intensity of mononuclear cell interstitial infiltrate, mononuclear cell exudation within glomerular capillaries ("glomerulitis"), tubular ectasia, tubular necrosis, exudation of mononuclear cells within tubular epithelial cells ("tubulitis"), and the ratio of mononuclear cells in interstitial tissues and in the peritubular capillaries (I/C ratio). A clinical response to an increased dose of steroids or a reduced dose of cyclosporine was correlated with the histologic picture. Tubulo-interstitial nephritis was identified in all but one patient with cyclosporine nephrotoxicity and only the finding of vasculitis allowed the identification of rejection with any certainly. However, the linear logistic regression method identified four histologic parameters--vasculitis, edema, glomerulitis, and I/C ratio, which were useful in differentiating the nephritis of cyclosporine nephrotoxicity from that of acute rejection in 94% of the biopsies. Although it is possible to precisely predict clinical response to antirejection therapy or reduction in cyclosporine dose based on histologic criteria, it is possible that cyclosporine toxicity, alone or in combination with rejection, may lead to chronic interstitial fibrosis responsible for late graft loss.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348988

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Blood cyclosporin concentrations and renal allograft dysfunction.

Authors:  D W Holt; J T Marsden; A Johnston; M Bewick; D H Taube
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  Glomerular endothelial changes in cyclosporine A-treated rats: scanning and transmission electron microscopic studies.

Authors:  M Kobayashi; S Takaya; H Koie; K Nagai
Journal:  Jpn J Surg       Date:  1991-03

3.  Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury.

Authors:  Sabrina Fan; Ching-Feng Weng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

4.  Minnesota experience with 85 pancreas transplants between 1978 and 1983.

Authors:  D E Sutherland; P L Chinn; F C Goetz; B A Elick; J S Najarian
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

5.  The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction.

Authors:  F L Delmonico; H Auchincloss; R H Rubin; P S Russell; N Tolkoff-Rubin; L T Fang; A B Cosimi
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

6.  Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients after cyclosporin-treated corneal grafting.

Authors:  F Kieselbach; P Kotanko
Journal:  Klin Wochenschr       Date:  1990-09-03

7.  Early results of cardiac transplantation at the Texas Heart Institute.

Authors:  I J Reece; O H Frazier; A Painvin; O J Okereke; L B Chandler; T W Krudewig; D A Cooley
Journal:  Thorax       Date:  1984-09       Impact factor: 9.139

8.  Renal allograft rejection in children and young adults: the Banff classification.

Authors:  H E Corey; S M Greenstein; V Tellis; R Schechner; I Greifer; B Bennett
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

9.  Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.

Authors:  G H Neild; D H Taube; R B Hartley; L Bignardi; J S Cameron; D G Williams; C S Ogg; C J Rudge
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

10.  Cyclosporin and renal graft histology.

Authors:  A J d'Ardenne; M S Dunnill; J F Thompson; D McWhinnie; R F Wood; P J Morris
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.